Trials / Conditions / RCC, Renal Cell Cancer

RCC, Renal Cell Cancer

7 registered clinical trials studyying RCC, Renal Cell Cancer — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally NCT07277972	Tianjin Medical University Cancer Institute and Hospital	Phase 2
Not Yet Recruiting	Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis NCT07246759	OncoHost Ltd.	—
Recruiting	Comparison of Outcomes and Surgical Time Between Cortical and Medullary Suture vs. Medullary-Only Suture: Cort NCT07190638	Brazilian Institute of Robotic Surgery	N/A
Recruiting	A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. NCT06883539	LaunXP Biomedical Co., Ltd.	Phase 1
Recruiting	Prospective Study on the Safety and Efficacy of Robot-Assisted Laparoscopic Partial Nephrectomy With Renal Art NCT06908902	The First Affiliated Hospital with Nanjing Medical University	N/A
Recruiting	A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therap NCT06769893	Xijing Hospital	N/A
Terminated	A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma NCT03207867	Novartis Pharmaceuticals	Phase 2